Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. - Wikidata - wikimedia - TriplyDB

Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.

Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.

http://www.wikidata.org/entity/Q38456223

about

Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions New treatment options for alcoholic hepatitis Meta-analysis of survival with the molecular adsorbent recirculating system for liver failure Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation Survival Benefits With Artificial Liver Support System for Acute-on-Chronic Liver Failure: A Time Series-Based Meta-Analysis Acute Kidney Injury in Patients with Cirrhosis Hepatorenal syndrome: Update on diagnosis and treatment The Role of Oxidative Stress and Antioxidants in Liver Diseases Potential Use of Biological Proteins for Liver Failure Therapy Drug Induced Liver Injury: Review with a Focus on Genetic Factors, Tissue Diagnosis, and Treatment Options Intensive care management of patients with liver disease: proceedings of a single-topic conference sponsored by the Brazilian Society of Hepatology Treatment and management of ascites and hepatorenal syndrome: an update Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.Protecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.Hepatic Encephalopathy: From the Pathogenesis to the New Treatments.Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control study Management of hepatic encephalopathy in the hospital Severe alcoholic hepatitis-current concepts, diagnosis and treatment options.Management of cirrhotic ascites Acute-on-chronic Liver Failure.Hepatorenal syndrome: aetiology, diagnosis, and treatment.Role of human albumin in the management of complications of liver cirrhosis.Characterisation of peripheral blood mononuclear cell microRNA in hepatitis B-related acute-on-chronic liver failure.Extracorporeal liver assist device to exchange albumin and remove endotoxin in acute liver failure: Results of a pivotal pre-clinical study Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review.Logistic regression model can reduce unnecessary artificial liver support in hepatitis B virus-associated acute-on-chronic liver failure: decision curve analysis.Artificial liver support system improves short- and long-term outcomes of patients with HBV-associated acute-on-chronic liver failure: a single-center experience.First clinical experience in 14 patients treated with ADVOS: a study on feasibility, safety and efficacy of a new type of albumin dialysis.Continuous molecular adsorbent recirculating system treatment in 69 patients listed for liver transplantation Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure--a prospective, randomised crossover study Comparative transcriptome analysis of peripheral blood mononuclear cells in hepatitis B-related acute-on-chronic liver failure.An Evaluation of the Usefulness of Extracorporeal Liver Support Techniques in Patients Hospitalized in the ICU for Severe Liver Dysfunction Secondary to Alcoholic Liver Disease.Clinical use of albumin.Alleviating liver failure conditions using an integrated hybrid cryogel based cellular bioreactor as a bioartificial liver support.Acute-on-chronic liver failure: a review.Acute kidney injury in acute liver failure: a review.Liver support strategies: cutting-edge technologies.Should MARS and Prometheus be used in patients with liver disease?Scoring systems predict the prognosis of acute-on-chronic hepatitis B liver failure: an evidence-based review.

P2860

Q26744689-557DE2DB-887A-443D-B811-C7CC9155E70D Q26751402-B95B2CFF-F672-4EF1-BCA0-709098D9E16D Q26771851-7C3A6ED2-8209-4A81-918B-827AEB7404F3 Q26772036-F13970B0-66F7-4DAC-98B9-742EAA2768AC Q26773433-28EEEB0A-98AC-4D76-BEFC-7DCEC6A17561 Q26775643-01DBCF3A-03F3-4920-B9E6-AD6D44DFF045 Q26777608-FF18FDF6-9880-40AC-8EFF-A42365EEDF2F Q26779146-C576B302-9714-462A-831E-891248D6BB11 Q26781325-0C21395B-1338-47C9-990E-CEE83A443641 Q26781892-D688D8FF-5E84-44ED-9950-8E9FDCA5BDA1 Q26865028-575F81A7-ED69-48EA-A0B1-F44CC53FE80E Q27000268-5D01593A-7DE2-46B7-BCE3-5604DA14C69B Q30234560-2C9E486B-B4BF-4D0C-BBD3-C8D5DD926953 Q30251763-4381AA65-9C7F-48C3-B35F-7B759FF5F68A Q30277969-BAA86E45-1AE3-4BC9-AD41-BE9F57B5E600 Q30381016-DE6B66EA-B637-42B5-81B0-E0318EE2FFC4 Q33558782-A2A39C17-5E23-4484-8F27-4C5BE4D795DB Q34028149-68923FDE-A9E3-4D28-B0E1-68FB03F1594C Q34404386-9D306EC2-5D5A-46C4-B356-6DC890992C1E Q34475601-E4CE34C1-797B-4BB1-8776-C02239171746 Q34542736-D4720A9C-53EA-4D0C-8819-80A453F2C0B9 Q35012890-F97CFFAB-D8BE-4640-A476-3DEC9520DF20 Q35574320-0F343CEF-45B2-46BB-A894-4D15CE0D2639 Q35943325-02C480D1-E110-422C-9B41-2D11F6D54C51 Q35970399-BBEA358F-B599-49EA-B9E1-DBA8797B0248 Q36038296-E5B515D3-F58F-422A-A5BA-E22C26AAE0E2 Q36040654-807718B0-8435-403E-9BCD-7B468BCC2C7D Q36154078-AA5E6715-E871-4866-8F87-83BC5D4699C7 Q36283332-68229232-4AF0-49F3-8133-4949A10A0232 Q36357186-74023506-127B-4172-BFF4-8C47F3709E23 Q36424482-96731A43-B848-4A6A-917B-F1E2D802EFA4 Q36565150-56BE3273-1EF2-46F8-9749-E254467FB4DF Q37246613-012345CC-5D15-40E1-AE58-61DE94673418 Q37370312-2A9118D8-C2E7-4AC8-B361-A9405671253F Q37581494-730DB1EF-3941-47FF-A2F9-25C9069DE20C Q37729728-8ECF6817-CD3F-4874-8494-017A09F91EF3 Q38153420-B7B89E11-804F-432D-B9B6-53D6E6826F44 Q38156043-98AFC8C7-3251-4A83-BD8A-02377DEDBC52 Q38193890-E3943845-58D6-4B3F-AA2C-0BFD948F9DCB Q38206836-ED15DC10-A248-4752-A5E4-159499FFF0ED

P2860

Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.

http://www.wikidata.org/entity/Q38456223

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Extracorporeal albumin dialysi ...... ver failure: the RELIEF trial.

@en

type

label

Extracorporeal albumin dialysi ...... ver failure: the RELIEF trial.

@en

prefLabel

Extracorporeal albumin dialysi ...... ver failure: the RELIEF trial.

@en

P1433

Q38456223-F2BA7DC2-D7B9-408E-A4FA-E35ECA23C8B1

P1476

Q38456223-0710938E-712A-4CA6-AB79-5E39CADF8E0A

P2093

Q38456223-24F78E53-1C64-4D67-B641-D2858FEC85B9

Q38456223-403E2766-DE8A-4303-82FF-3DB654BCE08A

Q38456223-40709048-23F9-4CFB-8024-66024D6D8C49

Q38456223-43FDBB06-0CD3-4475-B577-91082084E092

Q38456223-47AF38C2-6708-44BD-BE4F-1950DCC00741

Q38456223-715C2727-BD17-48D2-908C-862DF5C9A067

Q38456223-76F8DBC4-198D-4668-9DD2-BCD3387BB9D4

Q38456223-7BEF8A2A-C75B-4D6B-8F3E-5F4E5B6EF790

Q38456223-85F37590-7233-43A6-94EA-1B325197448A

Q38456223-8C6B4307-4EDA-4B55-B72C-4DD559017DFA

P2860

Q38456223-0C238DA9-4ACC-4632-96FF-A920AE1B8B3C

Q38456223-19E9AF92-A52A-47D2-AD14-D40F1A72ACB6

Q38456223-27B927E2-1876-415F-92BF-3B48BBA61AD1

Q38456223-2D50889B-A988-47ED-A70E-5CA86D4E47A7

Q38456223-35F2B522-E19C-46EB-A648-992FC3A5EF13

Q38456223-3CFA0CFA-33A3-4BF9-B64C-35427FFAF085

Q38456223-413DD654-B57C-415D-BACB-4FA8B23227F1

Q38456223-52EA3915-F269-4516-86B0-182126DFC8D7

Q38456223-5B6300F4-201D-495D-95A3-80483306E399

Q38456223-5CE37AAE-C0F8-47D0-A26E-AAAAE4666A9D

P304

Q38456223-1BEC28CC-6D8D-42C8-AAAA-EDCFDC0C2B2F

P31

Q38456223-AB3E9078-87BC-49AF-9BC8-EA03EADCB9A0

P356

Q38456223-D7122FC3-784D-4A48-BB15-E54D5178B2CC

P407

Q38456223-49381965-810C-42DF-908A-57B650F2DB0F

P433

Q38456223-3B74F13D-8E11-4A42-8DDB-ABE29860815C

P478

Q38456223-7DCA2C78-84A7-4AA7-B675-AFFCCDF09247

P50

Q38456223-1E2F577C-9607-4B06-B8F6-C4C58EB3E4A1

Q38456223-27F1D8F3-8702-4DFC-A52E-EB0A4C14E07C

Q38456223-481E14EA-4E26-4311-981D-561D0624AB3B

Q38456223-4D1C4F03-3C20-47D8-82C4-7BF768BD2617

Q38456223-5D51FCCF-B9FC-4C40-8E48-67AC92663869

Q38456223-7E94CFED-C3B3-4EF2-A65F-FAA606A5B636

Q38456223-B160E6AE-3420-4E8A-AC41-4D54DFD0EBBE

Q38456223-CBFEE842-A143-4B90-A760-5DC72322BF0F

P577

Q38456223-7E193031-1795-4CE8-8FFE-A2E5A9821602

P698

Q38456223-FE75BBC9-4335-44DD-A2E6-358C51ACAF3B

P921

Q38456223-FC162B6A-AAFB-48FF-89A3-939B7CA5D5DE

P356

P1433

P1476

Extracorporeal albumin dialysi ...... iver failure: the RELIEF trial

@en

P2093

Agustín Albillos

http://www.w3.org/2001/XMLSchema#string

Alexander Wilmer

http://www.w3.org/2001/XMLSchema#string

Alexander Zipprich

http://www.w3.org/2001/XMLSchema#string

Antonio Gasbarrini

http://www.w3.org/2001/XMLSchema#string

Faouzi Saliba

http://www.w3.org/2001/XMLSchema#string

Frederik Nevens

http://www.w3.org/2001/XMLSchema#string

Hartmut H-J Schmidt

http://www.w3.org/2001/XMLSchema#string

Johann Ockenga

http://www.w3.org/2001/XMLSchema#string

Julia Wendon

http://www.w3.org/2001/XMLSchema#string

Ludwig Kramer

http://www.w3.org/2001/XMLSchema#string

P2860

Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure

Septic AKI in ICU patients. diagnosis, pathophysiology, and treatment type, dosing, and timing: a comprehensive review of recent and future developments

Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure

Early goal-directed therapy in the treatment of severe sepsis and septic shock

A model to predict survival in patients with end-stage liver disease

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis.

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial.

Acute-on-chronic liver failure: pathophysiological basis of therapeutic options.

P304

1153-1162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.26185

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

Rafael Bañares

Philippe Mathurin

P577

2013-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23213075

http://www.w3.org/2001/XMLSchema#string

P921